Cargando…

Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells

Aims: Human parvovirus B19 (B19V) infection directly induces apoptosis and modulates CXCR4 expression of infected marrow-derived circulating angiogenic cells (CACs). This leads to dysfunctional endogenous vascular repair. Treatment for B19V-associated disease is restricted to symptomatic treatment....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zobel, Thomas, Bock, C.-Thomas, Kühl, Uwe, Rohde, Maria, Lassner, Dirk, Schultheiss, Heinz-Peter, Schmidt-Lucke, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466312/ https://www.ncbi.nlm.nih.gov/pubmed/30845701 http://dx.doi.org/10.3390/v11030227

Ejemplares similares

Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity
por: Van Linthout, Sophie, et al.
Publicado: (2018)

Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure
por: Pietsch, Heiko, et al.
Publicado: (2020)

Absent MicroRNAs in Different Tissues of Patients with Acquired Cardiomyopathy
por: Siegismund, Christine S., et al.
Publicado: (2016)

CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5
por: Lassner, Dirk, et al.
Publicado: (2018)

NS1 Specific CD8(+) T-Cells with Effector Function and TRBV11 Dominance in a Patient with Parvovirus B19 Associated Inflammatory Cardiomyopathy
por: Streitz, Mathias, et al.
Publicado: (2008)

Cardiac Migration of Endogenous Mesenchymal Stromal Cells in Patients with Inflammatory Cardiomyopathy
por: Schmidt-Lucke, Caroline, et al.
Publicado: (2015)

High Perforin‐Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long‐Term Mortality in Patients With Inflammatory Cardiomyopathy
por: Escher, Felicitas, et al.
Publicado: (2017)

Interferon-β Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2022)

Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy
por: Escher, Felicitas, et al.
Publicado: (2021)

Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome
por: Schmidt-Lucke, Caroline, et al.
Publicado: (2007)

Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2021)

Quantification of Circulating Endothelial Progenitor Cells Using the Modified ISHAGE Protocol
por: Schmidt-Lucke, Caroline, et al.
Publicado: (2010)

Clinicopathological Features of Telbivudine-Associated Myopathy
por: Ambang, Tomica, et al.
Publicado: (2016)

Effects of Telbivudine Treatment on the Circulating CD4(+) T-Cell Subpopulations in Chronic Hepatitis B Patients
por: Zheng, Yanhua, et al.
Publicado: (2012)

Myotoxicity of telbivudine in pre-existing muscle damage
por: Finsterer, Josef, et al.
Publicado: (2010)

Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditis
por: Fruhwald, Friedrich, et al.
Publicado: (2017)

Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
por: Osborn, Melissa K
Publicado: (2009)

Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine
por: Cai, Shaohang, et al.
Publicado: (2017)

Parvovirus B19-induced vascular damage in the heart is associated with elevated circulating endothelial microparticles
por: Bachelier, Katrin, et al.
Publicado: (2017)

Motor development delay in offspring is associated with prenatal telbivudine exposure
por: Zhou, Chengliang, et al.
Publicado: (2018)

Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy
por: Zeng, Jianyong, et al.
Publicado: (2019)

Efficacy and safety of telbivudine treatment for the prevention of HBV perinatal transmission
por: Ren, Cuicui, et al.
Publicado: (2020)

High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure
por: Scheiber, Daniel, et al.
Publicado: (2019)

Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: Outcomes of telbivudine treatment during pregnancy
por: Tan, Zhangmin, et al.
Publicado: (2016)

Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir
por: Koenig, Tobias, et al.
Publicado: (2021)

Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer
por: Rahbari, Nuh N, et al.
Publicado: (2011)

Complete Genome Sequence of Germline Chromosomally Integrated Human Herpesvirus 6A and Analyses Integration Sites Define a New Human Endogenous Virus with Potential to Reactivate as an Emerging Infection
por: Tweedy, Joshua, et al.
Publicado: (2016)

Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
por: Kim, Eun Hye, et al.
Publicado: (2013)

Telbivudine-Induced Myopathy: Clinical Features, Histopathological Characteristics, and Risk Factors
por: Lan, Min-Yu, et al.
Publicado: (2023)

Genotyping and phylogenetic analysis of canine parvovirus circulating in Egypt
por: Zaher, Kawther Sayed, et al.
Publicado: (2020)

Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice
por: Zhang, Hua, et al.
Publicado: (2014)

Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation
por: Han, Li-fen, et al.
Publicado: (2019)

Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease
por: Lee, Wei-Chen, et al.
Publicado: (2017)

Infant immune response to hepatitis B vaccine after fetal exposure to telbivudine
por: Li, Yandi, et al.
Publicado: (2022)

Genotyping and pathobiologic characterization of canine parvovirus circulating in Nanjing, China
por: Zhao, Yanbing, et al.
Publicado: (2013)

Genetic characterization of parvoviruses circulating in turkey and chicken flocks in Poland
por: Domanska-Blicharz, Katarzyna, et al.
Publicado: (2012)

Canine parvovirus (CPV-2) variants circulating in Nigerian dogs
por: Apaa, T. T., et al.
Publicado: (2016)

Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review
por: Zhao, Shushan, et al.
Publicado: (2010)

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
por: Wang, Y, et al.
Publicado: (2013)

Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion
por: Xu, Hongliang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j8emv1ri42h07p6skcd7gre5l6